Abstract
There are increasingly more patients seeking minimally invasive procedures, which have become more effective and safer in reducing the signs of facial aging. This study included 40 female adult patients who voluntarily underwent selected minimally invasive procedures (filling with hyaluronic acid and botulinum toxin injection) for facial rejuvenation. All patients were followed for a period of 6 months. They were evaluated with the use of questionnaires, a quality-of-life questionnaire (DLQI), the self-esteem scale of Rosenberg (EPM/Rosenberg), and a pain scale. The minimally invasive procedures resulted in improvement in quality of life and self-esteem, which were stronger the first 3 months after the procedures but remained at a higher level than that before treatment, even after 6 months. Hyaluronic acid with lidocaine in the formula is more comfortable for the patient as it makes the injection less painful.
Level of Evidence III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
References
American Society for Aesthetic Plastic Surgery (2011) Cosmetic surgery national data bank: 2011 statistics. http:www.surgery.org/download/2011stats.pdf. Accessed 10 March 2012
Carruthers J et al (2008) Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies—consensus recommendations. Plast Reconstr Surg 121(Suppl 5):5S–29S
Smith L, Cockerham K (2011) Hyaluronic acid dermal fillers: can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration? Patient Prefer Adherence 5:133–139
Carruthers J, Fagien S, Matarasso SL, Botox Consensus Group (2004) Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 114(Suppl 6):1S–22S
Ascher B, Talarico S, Cassuto D, Hexsel D, Jaen P, Monheit GD, Rzany B, Viel M (2010) International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)—part I: upper facial wrinkles. J Eur Acad Dermatol Venerol 24:1278–1284
Weinkle SH, Bank DE, Boyd CM, Gold MH, Thomas JA, Murphy DK (2009) A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juvéderm injectable gel with and without lidocaine. J Cosmet Dermatol 8(3):205–210
Dayan S, Arkins J, Patel A, Gal TA (2010) Double-blind randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type A injections on quality of life and self-esteem. Dermatol Surg 36:2088–2097
Finlay AY, Khan GK (1994) Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210–216
Dini GM, Quaresma M, Ferreira LM (2004) Translation into Portuguese, cultural adaptation and validation of the Rosenberg self-esteem scale. Rev Soc Bras Cir Plast 19(1):41–52
Huynh H, Feldt LS (1970) Conditions under which mean square ratios in repeated measurements designs have exact F-distributions. J Am Stat Assoc 65:1582–1589
Singer MJ, Andrade DF (1986) Análise de dados longitudinais [Analysis of longitudinal data], VII SINAPE. Brazilian Statistical Association, Campinas, SP, p 106
Stotland MA, Kowalski JW, Ray BB (2007) Patient-reported benefit and satisfaction with botulinum toxin type A treatment of moderate to severe glabellar rhytides: results from a prospective open-label study. Plast Reconstr Surg 120:1386–1393
Grimes PE (2004) A four-month randomized, double-masked evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI. Poster presented at the 62nd Annual Meeting of the American Academy of Dermatology, Washington, DC, 6–11 February 2004
Carruthers J, Carruthers A, Monheit GD (2010) Multicenter, randomized parallel group study of on a botulinum toxin A and hyaluronic acid dermal fillers (24-mg/mL smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. Dermatol Surg 36(Suppl 4):2121–2134
Sadick NS (2008) The impact of cosmetic interventions on quality of life. Dermatol Online J 14(8):2
Smith SR, Jones D, Thomas JA, Murphy DK, Beddingfield FC III (2010) Duration of wrinkle correction following repeat treatment with Juvederm hyaluronic acid fillers. Arch Dermatol Res 310(10):757–762
Monheit GD, Campbell RM, Neugent H et al (2010) Reduced pain with use of proprietary hyaluronic acid with lidocaine for correction of nasolabial folds: a patient-blinded, prospective, randomized controlled trial. Dermatol Surg 36(1):94–101
Beasley KL, Weiss MA, Weiss RA (2010) Soft tissue augmentation using a two-way connector to supplement hyaluronic acid filler with 1 % lidocaine hydrochloric acid with epinephrine 1:100,000: our experience and observations. Dermatol Surg 36(4):524–526
Levy PM, de Boulle K, Raspaldo H (2009) Comparison of injection comfort of a new category of cohesive hyaluronic acid filler with preincorporated lidocaine and a hyaluronic acid filler alone. Dermatol Surg 35(Suppl 1):332–336
Acknowledgments
This study was funded by a grant from Allergan, Inc. The Juvéderm, Surgiderm, and Botox materials were supplied by Allergan, Inc.
Disclosure
Dr. Alessandra Haddad is a consultant and investigator for and receives honoraria from Allergan, Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Aquino, M.S., Haddad, A. & Ferreira, L.M. Assessment of Quality of Life in Patients Who Underwent Minimally Invasive Cosmetic Procedures. Aesth Plast Surg 37, 497–503 (2013). https://doi.org/10.1007/s00266-012-9992-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-012-9992-0